Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review
R Gill, A Siddiqui, B Yee, MV DiCaro… - Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Hypertrophic cardiomyopathy (HCM) is characterized by excessive growth of myocardial
tissue, most commonly due to genetic mutations in sarcomere proteins. This can lead to …
tissue, most commonly due to genetic mutations in sarcomere proteins. This can lead to …
Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy (HOCM): Is HOCM passing another Crossroad?
T Lawrenz, D Lawin, C Stellbrink - Canadian Journal of Cardiology, 2024 - Elsevier
The evolution of therapeutic options in the treatment of Hypertrophic Obstructive
Cardiomyopathy (HOCM) was characterized by several milestones since its first description …
Cardiomyopathy (HOCM) was characterized by several milestones since its first description …